Anti-idiotype cancer vaccine 1A7 - Titan
Alternative Names: 1A7; anti-Id antibody 1A7; GD2 anti-idiotype cancer vaccine - Titan; TriGemLatest Information Update: 23 Sep 2021
At a glance
- Originator Titan Pharmaceuticals
- Class Cancer vaccines; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malignant melanoma; Neuroblastoma